March 22 (Reuters) - Bavarian Nordic A/S BAVA.CO :
* PUBLIC HEALTH AGENCY OF CANADA HAS ORDERED IMVAMUNE(®) SMALLPOX VACCINE TO NATIONAL STOCKPILE AT A TOTAL VALUE OF USD 31.2 MILLION.
* REG-BAVARIAN NORDIC RECEIVES ADDITIONAL SMALLPOX VACCINE ORDER FROM THE CANADIAN GOVERNMENT
* DELIVERIES OF VACCINES ARE EXPECTED TO OCCUR FROM Q1 2022 WITH ANTICIPATED COMPLETION IN 2023
* THIS ORDER, WHICH IS MADE UNDER AN EXISTING CONTRACT WITH PHAC, WILL HAVE NO IMPACT ON COMPANY'S FINANCIAL GUIDANCE FOR 2021.